Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

GSK-3β polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis.

Molecular neurobiology - 1 Dec 2013

Tang Hui, Shen Na, Jin Huijuan, Liu Dan, Miao Xiaoping, Zhu Ling-Qiang

Abstract excerpt

Glycogen synthase kinase 3 (GSK-3) is a well-known conserved and ubiquitous protein kinase and playing a pivotal role in neurodevelopment, neurogenesis, learning/memory, and neuronal cell death. Dysfunction of GSK-3 had been seen in multiple neurodegenerative and psychiatric diseases. Bipolar disorder and schizophrenia are two common psychiatric diseases first occur in adolescence or young adulthood. They share...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bipolar Disorder
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glycogen Synthase Kinase 3

Share to Glycogen Synthase Kinase 3 beta

Share to Polymorphism, Single Nucleotide

Share to Publication Bias

Share to Risk Factors

Share to Schizophrenia

Source

Identifiers

PMID: 23440732
DOI: 10.1007/s12035-013-8414-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

GSK-3β polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis.PMID 23440732Read ↗

No association of two common SNPs at position -1727 A/T, -50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population.Semantic proximity Read ↗

The GSK3B gene confers risk for both major depressive disorder and schizophrenia in the Han Chinese population.Semantic proximity Read ↗

No significant association between the genetic polymorphisms in the GSK-3 beta gene and schizophrenia in the Chinese population.Semantic proximity Read ↗

Meta-analysis demonstrates lack of association of the GSK3B -50C/T polymorphism with risk of bipolar disorder.Semantic proximity Read ↗

No association of GSK3beta gene (GSK3B) with Japanese schizophrenia.Semantic proximity Read ↗

Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium.Semantic proximity Read ↗

The involvement of GSK3beta in bipolar disorder: integrating evidence from multiple types of genetic studies.Semantic proximity Read ↗

Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder.Semantic proximity Read ↗

Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response.Semantic proximity Read ↗

Common Polymorphisms in the GSK3β Gene May Contribute to the Pathogenesis of Alzheimer Disease: A Meta-Analysis.Semantic proximity Read ↗

[Evaluation of the Association between Lithium Treatment and GSK3β Polymorphism in Bipolar Disorder Patients].Semantic proximity Read ↗

Genetic association and identification of a functional SNP at GSK3β for schizophrenia susceptibility.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.